Quantcast

Latest Mark Levis Stories

2012-12-10 16:52:14

'It caught us by surprise, how well this works.' -- Mark Levis, M.D., Ph.D. A new drug for patients with acute myeloid leukemia (AML) marked by a specific type of genetic mutation has shown surprising promise in a Phase II clinical trial. In more than a third of participants, the leukemia was completely cleared from the bone marrow, and as a result, many of these patients were able to undergo potentially curative bone marrow transplants, according to investigators at the Johns Hopkins...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related